892 related articles for article (PubMed ID: 34358469)
1. A proteogenomic portrait of lung squamous cell carcinoma.
Satpathy S; Krug K; Jean Beltran PM; Savage SR; Petralia F; Kumar-Sinha C; Dou Y; Reva B; Kane MH; Avanessian SC; Vasaikar SV; Krek A; Lei JT; Jaehnig EJ; Omelchenko T; Geffen Y; Bergstrom EJ; Stathias V; Christianson KE; Heiman DI; Cieslik MP; Cao S; Song X; Ji J; Liu W; Li K; Wen B; Li Y; Gümüş ZH; Selvan ME; Soundararajan R; Visal TH; Raso MG; Parra ER; Babur Ö; Vats P; Anand S; Schraink T; Cornwell M; Rodrigues FM; Zhu H; Mo CK; Zhang Y; da Veiga Leprevost F; Huang C; Chinnaiyan AM; Wyczalkowski MA; Omenn GS; Newton CJ; Schurer S; Ruggles KV; Fenyö D; Jewell SD; Thiagarajan M; Mesri M; Rodriguez H; Mani SA; Udeshi ND; Getz G; Suh J; Li QK; Hostetter G; Paik PK; Dhanasekaran SM; Govindan R; Ding L; Robles AI; Clauser KR; Nesvizhskii AI; Wang P; Carr SA; Zhang B; Mani DR; Gillette MA;
Cell; 2021 Aug; 184(16):4348-4371.e40. PubMed ID: 34358469
[TBL] [Abstract][Full Text] [Related]
2. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
[TBL] [Abstract][Full Text] [Related]
3. Proteogenomic landscape of squamous cell lung cancer.
Stewart PA; Welsh EA; Slebos RJC; Fang B; Izumi V; Chambers M; Zhang G; Cen L; Pettersson F; Zhang Y; Chen Z; Cheng CH; Thapa R; Thompson Z; Fellows KM; Francis JM; Saller JJ; Mesa T; Zhang C; Yoder S; DeNicola GM; Beg AA; Boyle TA; Teer JK; Ann Chen Y; Koomen JM; Eschrich SA; Haura EB
Nat Commun; 2019 Aug; 10(1):3578. PubMed ID: 31395880
[TBL] [Abstract][Full Text] [Related]
4. Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine.
Bilguun EO; Kaira K; Kawabata-Iwakawa R; Rokudai S; Shimizu K; Yokobori T; Oyama T; Shirabe K; Nishiyama M
BMC Cancer; 2020 Sep; 20(1):935. PubMed ID: 32993587
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung.
Okamoto T; Takada K; Sato S; Toyokawa G; Tagawa T; Shoji F; Nakanishi R; Oki E; Koike T; Nagahashi M; Ichikawa H; Shimada Y; Watanabe S; Kikuchi T; Akazawa K; Lyle S; Takabe K; Okuda S; Sugio K; Wakai T; Tsuchida M; Maehara Y
Ann Surg Oncol; 2018 Jun; 25(6):1564-1571. PubMed ID: 29500766
[TBL] [Abstract][Full Text] [Related]
6. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma.
Cui Y; Cui CA; Yang ZT; Ni WD; Jin Y; Xuan YH
Exp Mol Pathol; 2017 Apr; 102(2):347-353. PubMed ID: 28286162
[TBL] [Abstract][Full Text] [Related]
7. Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.
Krug K; Jaehnig EJ; Satpathy S; Blumenberg L; Karpova A; Anurag M; Miles G; Mertins P; Geffen Y; Tang LC; Heiman DI; Cao S; Maruvka YE; Lei JT; Huang C; Kothadia RB; Colaprico A; Birger C; Wang J; Dou Y; Wen B; Shi Z; Liao Y; Wiznerowicz M; Wyczalkowski MA; Chen XS; Kennedy JJ; Paulovich AG; Thiagarajan M; Kinsinger CR; Hiltke T; Boja ES; Mesri M; Robles AI; Rodriguez H; Westbrook TF; Ding L; Getz G; Clauser KR; Fenyö D; Ruggles KV; Zhang B; Mani DR; Carr SA; Ellis MJ; Gillette MA;
Cell; 2020 Nov; 183(5):1436-1456.e31. PubMed ID: 33212010
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials.
Niu Z; Jin R; Zhang Y; Li H
Signal Transduct Target Ther; 2022 Oct; 7(1):353. PubMed ID: 36198685
[TBL] [Abstract][Full Text] [Related]
9. Co-Expression Network Analysis Identified Genes Associated with Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma.
Qin S; Long X; Zhao Q; Zhao W
Cancer Invest; 2020 Jan; 38(1):13-22. PubMed ID: 31770041
[No Abstract] [Full Text] [Related]
10. IncRNA PLAC2 Upregulates CDK6 by Directly Targeting miR-29C to Promote Cell Proliferation in Lung Squamous Cell Carcinoma.
Zhao X; He X; Wang M; Zhang H; Cheng J; Wang H
Crit Rev Eukaryot Gene Expr; 2022; 32(8):55-67. PubMed ID: 36017916
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma.
Zhu M; Zhang C; Chen D; Chen S; Zheng H
Biomed Pharmacother; 2019 Sep; 117():108998. PubMed ID: 31207579
[TBL] [Abstract][Full Text] [Related]
12. Proteogenomic Characterization of Endometrial Carcinoma.
Dou Y; Kawaler EA; Cui Zhou D; Gritsenko MA; Huang C; Blumenberg L; Karpova A; Petyuk VA; Savage SR; Satpathy S; Liu W; Wu Y; Tsai CF; Wen B; Li Z; Cao S; Moon J; Shi Z; Cornwell M; Wyczalkowski MA; Chu RK; Vasaikar S; Zhou H; Gao Q; Moore RJ; Li K; Sethuraman S; Monroe ME; Zhao R; Heiman D; Krug K; Clauser K; Kothadia R; Maruvka Y; Pico AR; Oliphant AE; Hoskins EL; Pugh SL; Beecroft SJI; Adams DW; Jarman JC; Kong A; Chang HY; Reva B; Liao Y; Rykunov D; Colaprico A; Chen XS; Czekański A; Jędryka M; Matkowski R; Wiznerowicz M; Hiltke T; Boja E; Kinsinger CR; Mesri M; Robles AI; Rodriguez H; Mutch D; Fuh K; Ellis MJ; DeLair D; Thiagarajan M; Mani DR; Getz G; Noble M; Nesvizhskii AI; Wang P; Anderson ML; Levine DA; Smith RD; Payne SH; Ruggles KV; Rodland KD; Ding L; Zhang B; Liu T; Fenyö D;
Cell; 2020 Feb; 180(4):729-748.e26. PubMed ID: 32059776
[TBL] [Abstract][Full Text] [Related]
13. FGF19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas.
Zhang X; Kong M; Zhang Z; Xu S; Yan F; Wei L; Zhou J
Thorac Cancer; 2017 Nov; 8(6):655-665. PubMed ID: 28906590
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑143‑3p suppresses cell growth and invasion in laryngeal squamous cell carcinoma via targeting the k‑Ras/Raf/MEK/ERK signaling pathway.
Zhang F; Cao H
Int J Oncol; 2019 Feb; 54(2):689-701. PubMed ID: 30535502
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Notch1 induces apoptosis and inhibits cell proliferation and metastasis in laryngeal squamous cell carcinoma.
Dai MY; Fang F; Zou Y; Yi X; Ding YJ; Chen C; Tao ZZ; Chen SM
Oncol Rep; 2015 Dec; 34(6):3111-9. PubMed ID: 26398771
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma.
Li Y; Tao C; Dai L; Cui C; Chen C; Wu H; Wei Q; Zhou X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30563928
[TBL] [Abstract][Full Text] [Related]
18. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
[TBL] [Abstract][Full Text] [Related]
19. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
[TBL] [Abstract][Full Text] [Related]
20. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways.
Soltis AR; Bateman NW; Liu J; Nguyen T; Franks TJ; Zhang X; Dalgard CL; Viollet C; Somiari S; Yan C; Zeman K; Skinner WJ; Lee JSH; Pollard HB; Turner C; Petricoin EF; Meerzaman D; Conrads TP; Hu H; ; Shriver CD; Moskaluk CA; Browning RF; Wilkerson MD
Cell Rep Med; 2022 Nov; 3(11):100819. PubMed ID: 36384096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
